YOU STOPPED AT: “ HOW YOUR RESULT COMPARES TO SIMILAR PATIENTS Risk Stratification Context COMPARISON TO OTHER...

COMPLETING YOUR MSKCC NOMOGRAM COMPARISON & CLINICAL CONTEXT

Let me finish the risk stratification comparison and then explain what your 72-76% result actually means for your specific situation.

---

HOW YOUR RESULT COMPARES TO SIMILAR PATIENTS - COMPLETE

Risk Stratification Context

LOW-RISK PATIENTS (Better than you):
├─ PSA <10 ng/mL
├─ Gleason ≤6
├─ pT2 stage
├─ Negative margins
├─ 5-year recurrence-free: 85-95%
└─ Your comparison: You have higher risk due to Gleason 7 + positive margin

YOUR INTERMEDIATE-RISK CATEGORY (Your situation):
├─ PSA 4-10 ng/mL ✓ (You: 5.14)
├─ Gleason 7 ✓ (You: 3+4)
├─ pT2 stage ✓ (You: pT2)
├─ Focal positive margin ✓ (You: apex only)
├─ 5-year recurrence-free: 70-80%
└─ Your result: 72-76% (right in this range)

HIGH-RISK PATIENTS (Worse than you):
├─ PSA >10 ng/mL
├─ Gleason 8-10
├─ pT3a-pT3b stage
├─ Extensive positive margins
├─ 5-year recurrence-free: 40-60%
└─ Your comparison: You have significantly better prognosis

VERY HIGH-RISK PATIENTS (Much worse than you):
├─ PSA >20 ng/mL
├─ Gleason 9-10
├─ pT4 stage
├─ Seminal vesicle invasion
├─ 5-year recurrence-free: <40%
└─ Your comparison: You have much better prognosis

---

WHAT YOUR 72-76% RESULT ACTUALLY MEANS

Translating the Nomogram into Real-World Outcomes

YOUR 5-YEAR RECURRENCE-FREE PROBABILITY: 72-76%

INTERPRETATION #1: Individual Perspective
┌────────────────────────────────────────────────────────────┐
│ "What are MY chances of staying cancer-free?"              │
│                                                            │
│ Answer: 72-76 out of 100 men like you will NOT have        │
│ biochemical recurrence (PSA rise) in the next 5 years.     │
│                                                            │
│ Flip side: 24-28 out of 100 men like you WILL have         │
│ biochemical recurrence in the next 5 years.                │
│                                                            │
│ Your personal odds: Either you're in the 72-76% group      │
│ (no recurrence) or the 24-28% group (recurrence).          │
│ The nomogram can't tell which group you'll be in.          │
└────────────────────────────────────────────────────────────┘

INTERPRETATION #2: What "Biochemical Recurrence" Means
┌────────────────────────────────────────────────────────────┐
│ Biochemical recurrence = PSA rises above 0.2 ng/mL          │
│                                                            │
│ Important clarifications:                                  │
│ • NOT the same as clinical recurrence                      │
│ • NOT the same as metastatic disease                       │
│ • NOT the same as cancer symptoms                          │
│ • Just means PSA is detectable again                       │
│ • Detected early, before any other signs                   │
│ • Still highly treatable with salvage therapy              │
│ • Many men live 10+ years after biochemical recurrence     │
└────────────────────────────────────────────────────────────┘

INTERPRETATION #3: Time Horizon
┌────────────────────────────────────────────────────────────┐
│ "What about beyond 5 years?"                               │
│                                                            │
│ 5-year result: 72-76% recurrence-free                      │
│ 10-year result: 60-65% recurrence-free                     │
│ 15-year result: ~55% recurrence-free (estimated)           │
│                                                            │
│ Key point: Risk continues to accumulate over time.         │
│ This is why lifelong PSA surveillance is recommended.      │
└────────────────────────────────────────────────────────────┘

---

WHAT FACTORS HELPED YOUR NOMOGRAM RESULT

Why You're at 72-76% (Not Higher, Not Lower)

FACTORS THAT IMPROVED YOUR RESULT (Favorable):
✓ pT2 STAGE (Organ-confined disease)
  ├─ Best possible surgical stage
  ├─ No extension beyond prostate capsule
  ├─ Reduced your recurrence risk by ~15-20%
  └─ This is why pT2 is so important

✓ NEGATIVE SEMINAL VESICLE INVASION
  ├─ No cancer in seminal vesicles
  ├─ Reduced your recurrence risk by ~10-15%
  └─ Major favorable prognostic factor

✓ NEGATIVE EXTRAPROSTATIC EXTENSION
  ├─ No cancer outside prostate capsule
  ├─ Reduced your recurrence risk by ~10-15%
  └─ Another major favorable prognostic factor

✓ EXCELLENT PSA RESPONSE TO SURGERY
  ├─ PSA dropped from 5.14 to 0.009 ng/mL
  ├─ Now undetectable at 9.5 months
  ├─ Suggests complete cancer removal
  ├─ Not directly in nomogram, but very reassuring
  └─ Predicts lower recurrence risk

FACTORS THAT REDUCED YOUR RESULT (Unfavorable):
✗ GLEASON 7 (3+4) SCORE
  ├─ Intermediate-grade cancer
  ├─ 30% Gleason 4 component
  ├─ Increased your recurrence risk by ~10-15%
  └─ Main reason you're not in low-risk category

✗ FOCAL POSITIVE MARGIN AT APEX
  ├─ Cancer cells at surgical edge
  ├─ Increased your recurrence risk by ~8-12%
  ├─ But only focal (not extensive)
  └─ Reason you're not at 80%+ recurrence-free

✗ PRE-OPERATIVE PSA 5.14 ng/mL
  ├─ Intermediate level
  ├─ Increased your recurrence risk by ~5-8%
  └─ Contributed to intermediate-risk category

✗ PERINEURAL INVASION PRESENT
  ├─ Cancer cells along nerve sheaths
  ├─ Increased your recurrence risk by ~3-5%
  └─ Minor contributor to overall risk

BOTTOM LINE:
Your favorable factors (pT2, no SVI, no EPE) kept you from being
high-risk. Your unfavorable factors (Gleason 7, positive margin)
kept you from being low-risk. Result: Intermediate at 72-76%.

---

YOUR NOMOGRAM RESULT IN CONTEXT OF NCCN GUIDELINES

How This Aligns with Current Treatment Recommendations

According to NCCN Guidelines for Prostate Cancer (2024-2025), your nomogram result supports the recommended approach:

YOUR NOMOGRAM RESULT: 72-76% recurrence-free at 5 years
YOUR NCCN RECOMMENDATION: Observation with PSA surveillance

WHY THIS ALIGNMENT MAKES SENSE:

1. OBSERVATION IS APPROPRIATE BECAUSE:
   ├─ Your 72-76% recurrence-free rate is favorable
   ├─ 70-80% of intermediate-risk patients don't rec